Pancreatic Cancer Research

ResearcherComenius University BratislavaActive in the last 2 years

Erika Halášová

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2458-1391; OpenAlex author ID A5060657800. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Anti-Tumor Effects of Statins in Pancreatic Ductal Adenocarcinoma Cells. Last author DOI 10.3390/ijms27072972↗
  2. Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2025.05.005↗
  3. Establishment of PANDA - a new human pancreatic ductal adenocarcinoma cell line with 3D cell culture technology. Co-author DOI 10.4149/210924n1360↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ján Strnádel · 2 shared papers, 2022–2026 · strength 0.37
  2. Veronika Kucháriková · 1 shared paper, 2026 · strength 0.26
  3. Kari Hemminki · 1 shared paper, 2025 · strength 0.22
  4. Božena Smolková · 1 shared paper, 2025 · strength 0.22
  5. Saba Selvi · 1 shared paper, 2025 · strength 0.22
  6. Ľudmila Vodičková · 1 shared paper, 2025 · strength 0.22
  7. Pavel Vodička · 1 shared paper, 2025 · strength 0.22
  8. Daniele Campa · 1 shared paper, 2025 · strength 0.22
  9. Manuel Gentiluomo · 1 shared paper, 2025 · strength 0.22
  10. Cosmeri Rizzato · 1 shared paper, 2025 · strength 0.22
  11. Michael Bouvet · 1 shared paper, 2022 · strength 0.11
  12. Romana Zahumenska · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.